Moderna announces agreement with Thermo Fisher Scientific for manufacturing of Moderna’s COVID-19 vaccine
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines
Compared to traditional development approaches, mechanistic modelling saves significant time and materials on process development
Access to mechanical circulatory support devices is critical for advanced heart failure patients and can improve survival, clinical outcomes and quality of life
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
Expanding the potential of graphene derivatives for societal challenges
University of Liverpool student shares her work analyzing Egyptian mirrors
Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory
New smartphone-sized test device uses innovative ‘lab on chip’ technology for rapid, accurate results
The collaboration makes it easier for customers to choose the most suitable tools to address their analytical needs for both large and small molecules
Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally
A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%